Nanolive SA
PrivateLast Round
Series C
Sep 21, 2022
Total Funding Raised
$25M
Company Overview
Nanolive SA operates in Healthcare & Life Sciences and is based in Switzerland. Its latest recorded funding round was a Series C round in September 2022.
Nanolive SA is a biotechnology company that develops and commercializes label-free, non-invasive live cell imaging and analysis platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Imaging, Drug Discovery, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanolive SA Comparables
Compare Nanolive SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tomocube Inc. | 87% | |
| Interherence GmbH | 81% | |
| Bruker | 78% |
For institutional investors. Book with your work email.
Nanolive SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 21, 2022 | ||||
| Seed | Nov 4, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanolive SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series C |
| Swisscom Ventures | Series C |
| Innoviva | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2022
$22M round led by Innoviva and Taiwania Capital.
- Nov 4, 2014
$3M raised in Seed round.
For institutional investors. Book with your work email.
Nanolive SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanolive SA's valuation, stock price, and market status.
Is Nanolive SA a public or private company?
Nanolive SA is a private company.
What is the current stock price of Nanolive SA?
Nanolive SA is a private company, so its shares have no public market price. Caplight tracks Nanolive SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanolive SA worth (valuation)?
Valuation information for Nanolive SA is not publicly available.
Can I buy Nanolive SA stock?
Nanolive SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanolive SA's last funding round?
Nanolive SA's most recent funding round was Series C on September 21, 2022.
Who are the main investors in Nanolive SA?
Key investors in Nanolive SA include Taiwania Capital, Innoviva.
Will Nanolive SA IPO soon?
No public IPO plans have been announced for Nanolive SA.
How can I track Nanolive SA secondary market activity?
Caplight tracks bids, offers, and trades in Nanolive SA's shares on secondary markets.